Tags : Digital Therapeutic


Boehringer Ingelheim and Click Collaborate on Digital Therapy for Behaviour

Shots: Click to receive $500M as up front, funding for research and development activities, clinical, regulatory & commercial milestones along with royalties on sales of CT-155 globally, will lead research and development activities and support Boehringer Ingelheim in global commercialization activities The companies will join their expertise to develop the mobile application, CT-155, which combines […]Read More

DigiHealth Regulatory

World’s First App-Based Nicotine Addiction Treatment Receives the MHLW’s Approval

Shots: On Aug 21, 2020, CureApp receives MHLW’s approval for the manufacturing and sale of Asia’s first therapeutics app, the “CureApp SC Nicotine Addiction Treatment App and CO Checker’’. The company plans to receive insurance reimbursement and release CureApp SC in FY2020 CureApp SC is a prescription medical device designed to aid patients receiving outpatient […]Read More


Akili’s EndeavorRx Receives the US FDA’s Approval as the First

Shots: The FDA’s De novo clearance is based on five clinical studies in 600+ children diagnosed with ADHD, which demonstrated an improved measure of attention. After 4wks., one-third of children had no longer measurable attention deficit on at least one measure of objective attention Change in child’s day-to-day impairments following @1mos. treatment with EndeavorRx which […]Read More